ArticleBrain and behavior2026
Associations Between Cardiovascular Risk Factors and Neurofilament Light Levels Among US Mexican American Adults.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
backgroundThis study explores the relationship between neurofilament light (NfL) levels, a biomarker of neuronal injury, and cardiovascular health and vascular injury among US Mexican American (MA) and non-Latino White (NLW) adults.
methodsData from 1317 participants in the Health and Aging Brain Study: Health Disparities (HABS-HD) were analyzed, including phenotypic, neuroimaging, and plasma NfL data. Cardiovascular health factors included hypertension, diabetes, and cardiovascular disease (CVD), while vascular injury markers were white matter hyperintensities (WMH).
resultsWe found that NfL levels differed between MA and NLW participants based on diabetes and CVD diagnosis, with more pronounced differences in the MA group. In addition, the association between WMH volume and NfL was steeper in the MA group.
conclusionThese findings suggest NfL's potential as a prognostic biomarker for CVD and neurodegeneration, especially in MA adults. Further research is needed to understand these associations and develop targeted prevention strategies for brain aging disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.